Literature DB >> 18689029

The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs.

T E Starzl, K A Porter, N Kashiwagi, I Y Lee, W J Russsell, C W Putnam.   

Abstract

Ten nondiabetic dogs were submitted to a procedure called splanchnic division which directed the nutrient rich venous return from the intestines into the left lobes of the liver and the hormone rich pancreaticogastroduodenosplenic venous return into the right lobes. Two months later, the right lobes had undergone the expected gross and microscopic hypertrophy. Compared with the abnormal shrunken and glycogen-depleted hepatocytes of the left lobes, the large and otherwise normal hepatocytes of the right lobes had a higher rate of cell division as judged by microscopic examination, measurements of deoxyribonucleic acid synthesis and the results of autoradiography. Both sides had greater cell replication than in the livers of normal unaltered dogs. The dominance of the right lobes following splanchnic division was almost completely eliminated by the prior creation of alloxan-induced diabetes in four dogs and by the performance of total pancreatectomy at the same time as splanchnic division in six dogs. In these ten diabetic dogs, which were treated with subcutaneously administered insulin for the two month period of the post operative study, hepatic lobar and cell size were nearly equal on both sides. By light and electron microscopy, the hepatocytes on both sides had abnormalities, somewhat less pronounced on the right. However, the most active cell division was now transferred to the left lobes. The results with alloxan-induced diabetes were similar to those after total pancreatectomy, except the lipid deposits were less on both liver sides in the alloxan experiments, and the glycogen was selectively reduced in the right lobes. The latter finding presumably was due to the continued action of glucagon in dogs made diabetic with alloxan. Twelve nondiabetic dogs had a procedure called partial portacaval transposition which directed systemic venous blood from the hindquarters, kidneys and adrenal glands into the left lobes of the liver and the total splanchnic venous return into the right lobes. Two months later, the degree of relative hypertrophy and hyperplasia of the glycogen rich right lobes was even greater than after splanchnic division, as was the morphologic damage to the left lobar hepatocytes. The degree of right lobar hypertrophy following partial portacaval transposition was reduced but not eliminated by pre-existing alloxan-induced diabetes in four dogs and by concomitant total pancreatectomy in six more dogs. The dogs were subcutaneously treated with insulin. Structurally, the hepatocytes on the right side after two months were in better condition than were those on the left, although both were abnormal. The dominance of cell division on the right side was reduced, as judged by standard microscopy and by autoradiography, but there was not a shifting of sides. The biochemical analyses reflected the presence or absence of glucagon. These findings are consistent with our earlier multifactorial hypothesis which holds that portal hepatotrophic factors are mainly interreacting hormones generated by splanchnic organs and delivered straight to the liver and that the hormone interrelationships might have augmented significance because of the high concentration of nutritional substrate in the same venous blood. The observations also substantiate by direct testing the suggestion that insulin is the most important hepatotropic factor and that it profoundly affects many aspects of liver cell structure, division and function.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 18689029      PMCID: PMC2728061     

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  34 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER.

Authors:  T E STARZL; T L MARCHIORO; D T ROWLANDS; C H KIRKPATRICK; W E WILSON; D RIFKIND; W R WADDELL
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

3.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

4.  Glycogen fractions of liver and muscle.

Authors:  W L BLOOM; G T LEWIS; M Z SCHUMPERT; T M SHEN
Journal:  J Biol Chem       Date:  1951-02       Impact factor: 5.157

5.  Evaluation of a humoral factor in liver regeneration utilizing liver transplants.

Authors:  B Fisher; P Szuch; E R Fisher
Journal:  Cancer Res       Date:  1971-03       Impact factor: 12.701

6.  Influence of blood supply on regeneration of liver transplants.

Authors:  S Lee; J E Keiter; H Rosen; R Williams; J G Chandler; M J Orloff
Journal:  Surg Forum       Date:  1969

Review 7.  The extracellular regulation of liver regeneration.

Authors:  B Sigel
Journal:  J Surg Res       Date:  1969-06       Impact factor: 2.192

8.  A colorimetric method for estimating serum triglycerides.

Authors:  M J Fletcher
Journal:  Clin Chim Acta       Date:  1968-11       Impact factor: 3.786

9.  Incorporation of pyrimidine deoxyribonucleosides into liver lipids and other components.

Authors:  W C Schneider; A E Greco
Journal:  Biochim Biophys Acta       Date:  1971-02-11

10.  A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells.

Authors:  A V Loud
Journal:  J Cell Biol       Date:  1968-04       Impact factor: 10.539

View more
  24 in total

1.  The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions.

Authors:  J Hayakawa; H Motohashi; M Sairenji; O Kobayashi; M Takahashi; Y Usuda
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Insulin and glucagon therapy of acute hepatic failure.

Authors:  K Fujiwara; I Ogata; Y Sato; T Tomiya; Y Ohta; Y Oka; S Nagoshi; S Yamada; N Masaki; K Takatsuki
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 3.  The unfinished legacy of liver transplantation: emphasis on immunology.

Authors:  Thomas E Starzl; Fadi G Lakkis
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

4.  Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice.

Authors:  C Ricordi; Y Zeng; A Tzakis; R Alejandro; A J Demetris; J Fung; D R Bereiter; D H Mintz; T E Starzl
Journal:  Transplantation       Date:  1991-10       Impact factor: 4.939

5.  The effect upon the liver of evisceration with or without hormone replacement.

Authors:  T E Starzl; A Francavilla; K A Porter; J Benichou
Journal:  Surg Gynecol Obstet       Date:  1978-04

6.  The mother lode of liver transplantation, with particular reference to our new journal.

Authors:  T E Starzl
Journal:  Liver Transpl Surg       Date:  1998-01

7.  Acute effects of distal pancreatectomy on portal and peripheral blood insulin concentrations in patients undergoing total gastrectomy.

Authors:  J Hayakawa; A Tsuburaya; H Motohashi; M Sairenji; O Kobayashi; K Suzuki; Y Usuda
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

8.  Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells.

Authors:  L Polimeno; A Azzarone; Q H Zeng; C Panella; V Subbotin; B Carr; B Bouzahzah; A Francavilla; T E Starzl
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

9.  Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion.

Authors:  C W Putnam; K A Porter; T E Starzl
Journal:  Ann Surg       Date:  1976-08       Impact factor: 12.969

10.  A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis.

Authors:  H Oka; K Fujiwara; K Okita; H Ishii; A Sakuma
Journal:  Gastroenterol Jpn       Date:  1989-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.